The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenvatinib in combination with everolimus in metastatic renal cell carcinoma (mRCC) resistant to antiangiogenic targeted therapy: An initial Russian experience.
 
Maria Volkova
No Relationships to Disclose
 
Olga Igorevna Samuseva
No Relationships to Disclose
 
Anna Sergeevna Olshanskaya
No Relationships to Disclose
 
Vsevolod B. Matveev
No Relationships to Disclose